Mol Cell Biol, April 1998, p. 1935-1945, Vol. 18, No. 4
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Divisions of Basic Sciences1 and Medical Sciences,3 Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, and Department of Biochemistry, Howard Hughes Medical Institute, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 088542
Received 25 August 1997/Returned for modification 7 October 1997/Accepted 26 January 1998
Under conditions of environmental stress, prokaryotes and lower
eukaryotes such as the yeast Saccharomyces cerevisiae
selectively utilize particular subunits of RNA polymerase II (pol II)
to alter transcription to patterns favoring survival. In S. cerevisiae, a complex of two such subunits, RPB4 and RPB7,
preferentially associates with pol II during stationary phase; of these
two subunits, RPB4 is specifically required for survival under
nonoptimal growth conditions. Previously, we have shown that RPB7
possesses an evolutionarily conserved human homolog, hsRPB7, which was
capable of partially interacting with RPB4 and the yeast
transcriptional apparatus. Using this as a probe in a two-hybrid
screen, we have now established that hsRPB4 is also conserved in higher
eukaryotes. In contrast to hsRPB7, hsRPB4 has diverged so that it no
longer interacts with yeast RPB7, although it partially complements
rpb4
phenotypes in yeast. However, hsRPB4 associates
strongly and specifically with hsRPB7 when expressed in yeast or in
mammalian cells and copurifies with intact pol II. hsRPB4 expression in humans parallels that of hsRPB7, supporting the idea that the two
proteins may possess associated functions. Structure-function studies
of hsRPB4-hsRPB7 are used to establish the interaction interface
between the two proteins. This identification completes the set of
human homologs for RNA pol II subunits defined in yeast and should
provide the basis for subsequent structural and functional characterization of the pol II holoenzyme.
Present address: Small Molecule Therapeutics, Monmouth Junction,
N.J.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|